Characterisation of the metabolic syndrome in type 2 diabetics treated at the Provincial Centre of Pinar del Río

Authors

  • Yazuina Fuentes-de la Rosa Universidad de Ciencias Médicas de Pinar del Río. Facultad de Ciencias Médicas Dr Ernesto Guevara de la Serna. Pinar del Río, Cuba. https://orcid.org/0000-0002-7691-5413
  • José Caridad Díaz Cabrera Universidad de Ciencias Médicas de Pinar del Río. Facultad de Ciencias Médicas Dr Ernesto Guevara de la Serna. Pinar del Río, Cuba. https://orcid.org/0000-0003-2787-7446
  • Marvelia Díaz Calzada Policlínico Universitario Luis Augusto Turcios Lima. Pinar del Río, Cuba.
  • Lazara Maidelys Rodríguez-Sardiñas Universidad de Ciencias Médicas de Pinar del Río. Facultad de Ciencias Médicas Dr Ernesto Guevara de la Serna. Pinar del Río, Cuba. https://orcid.org/0000-0003-3730-414X
  • Yohanka Pérez Alvarez Universidad de Ciencias Médicas de Pinar del Río. Facultad de Ciencias Médicas Dr Ernesto Guevara de la Serna. Pinar del Río, Cuba. https://orcid.org/0000-0002-8834-4902

Keywords:

METABOLIC SYNDROME, DIABETES MELLITUS, TYPE 2, INSULIN RESISTANCE.

Abstract

Introduction: Metabolic Syndrome is a serious problem, increasing its incidence, associated with Diabetes Mellitus.

Objective: To characterise the Metabolic Syndrome in type 2 diabetic patients in the Diabetic Care Centre of Pinar Del Rio in the period January-September 2020.

Methods: An observational, descriptive, cross-sectional, descriptive study was carried out in the Diabetic Care Centre of Pinar Del Rio, January-September 2021. The universe consisted of 88 patients with type 2 diabetes mellitus and the sample consisted of 44. The information extracted from the medical records was processed using SPSS version 22, calculating frequencies and the chi-squared test (X2), which was significant if p<0.05. Metabolic syndrome was diagnosed using NCEP-ATP III criteria.

Results: Metabolic syndrome was diagnosed in 70,45 % of patients, predominantly female (67,74 %) and aged between 60 and 69 years, with a preponderance of type 2 diabetic patients, predominantly postmenopausal women. Arterial Hypertension, abdominal obesity and elevated triglycerides were the most frequent components and uric acid and Aspartate Amino Transferase, the highest biochemical parameters.

Conclusions: Metabolic syndrome appears frequently in patients with type 2 diabetes mellitus with elevated parameters such as uric acid and ASAT.

Downloads

Download data is not yet available.

References

1. Rufín-Gómez LÁ, Martínez-Morejón A, Rufín-Bergado A, Méndez-Martínez J. Síndrome metabólico, un factor de riesgo en pacientes de COVID-19. Rev. Med. Electrón [Internet]. 2022 Feb [citado 29/05/2022]; 44(1): 142-154. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242022000100142&lng=es.

2. Martínez Martínez R, Castañeda Guillot CD, Pimienta Concepción I. Microbiota intestinal y diabetes. Universidad y Sociedad [Internet]. 7mar.2022 [citado 29/05/2022]; 14(2): 158-63. Available from: https://rus.ucf.edu.cu/index.php/rus/article/view/2688

3. Trujillo-Hernández B, Trujillo-Magallón E, Trujillo-Magallón M, Brizuela-Araujo CA, García-Medina MA, González-Jiménez M A, et al . Frecuencia del síndrome metabólico y factores de riesgo en adultos con y sin diabetes mellitus e hipertensión arterial. Rev. salud pública [Internet]. 2017 Oct [citado 18/07/2023]; 19(5): 609-616. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0124-00642017000500609&lng=es.

4. Rodrigues Ticiana C, Canani Luis H, Gross JL. Síndrome metabólica, resistência à ação da insulina e doença cardiovascular no diabete melito tipo 1. Arquivos Brasileiros de Cardiologia [Internet]. 2010 [citado 29/05/2022]; 94(1): 134-139. Disponible en: https://www.scielo.br/j/abc/a/TWfv7JgTjMY4gpGLKrXSdfB/

5. Cabrera E, Rodríguez V, Rodríguez J, Cubas I, Álvarez A, Arnold Y, et al. Evaluación de tres metodologías para la predicción del riesgo de alteraciones del metabolismo de la glucosa en sujetos con sobrepeso y obesidad. Rev Cub de Endocrinol [Internet]. 2017 [Citado 29/06/2019]; 28(2). Disponible en: http://www.revendocrinologia.sld.cu/index.php/endocrinologia/article/view/69

6. Kabadi UM. Major Pathophysiology in Prediabetes and Type 2 Diabetes: Decreased Insulin in Lean and Insulin Resistance in Obese. Journal of the Endocrine Society [Internet]. 2017 [Citado 29/06/2019]; 1(6): 742–750. Disponible en: https://doi.org/10.1210/js.2016-1116

7. Coz Calumani J, Cuba Sancho J. Intervenciones para prevenir el síndrome metabólico en adolescentes. Rev Cubana Enfermer [Internet]. 2021 Dic [citado 29/05/2022]; 37(4): e4122. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03192021000400016&lng=es.

8. Vera-Ponce V, Talavera J, Torres-Malca J, De-La-Cruz-Vargas J. Combinaciones de síndrome metabólico y riesgo de diabetes mellitus. Revista Cubana de Medicina Militar [Internet]. 2022 [citado 29/05/2022]; 51(1): e02201651. Disponible en: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/1651

9. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2018 [Internet]. La Habana: MINSAP; 2019 [citado 10/12/2019]. Disponible en: http://www.bvscuba.sld.cu/2017/11/20/anuario-estadistico-de-salud-de-cuba/

10. Pimazoni Netto A. Conducta Terapéutica no Diabetes tipo 2: Algoritmo SBD [Internet]. São Paulo; 2019 [citado 10/12/2019]. Disponible en: https://nutritotal.com.br/pro/wp-content/uploads/sites/3/2019/09/algoritmo_sbd_2019_2.pdf

11. American Diabetes Association. Standards of medical care in diabetes 2014. Diabetes Care [Internet]. 2014 [20/11/2020]; 37(Suppl 1): S14‒80. Disponible en: https://care.diabetesjournals.org/content/37/Supplement_1/S14

12. Morejón Giraldoni A, Benet Rodríguez M, Díez y Martínez de la Cotera E, García Torres D, Salas Rodríguez V, Ordúñez García P. Síndrome metabólico en un área de salud de Cienfuegos. Segunda medición de CARMEN. Rev Finlay [Internet]. 2011 [citado 21/02/2019]; 1(1): 6-16. Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/24

13. Araujo Duran Y. Caracterización del síndrome metabólico en pacientes de la provincia de Santiago de Cuba, año 2010. Rev Latinoamer Patol Clin [Internet]. 2013 jun [citado 21/02/2019]; 60(2): 96-101. Disponible en: http://www.medigraphic.com/pdfs/patol/pt-2013/pt132d.pdf

14. Gómez Torres FD, González Lemoine M, Legrá Sevila M, Pereña Haber L, López Herrera A. Prevalencia del síndrome metabólico en población de 15 a 74 años del municipio Guantánamo. Rev Inf Cient [Internet]. 2017 [citado 12/12/2019]; 96(3): 454-465. Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/290/2819

15. Fonte Medina N, Sanabría Negrín JG, Bencomo Fonte LM, Fonte Medina A, Rodríguez Negreria IL. Factores de riesgo asociados y prevalencia de síndrome metabólico en la tercera edad. Rev Ciencias Médicas [Internet]. 2014 Dic [citado 26/12/2019]; 18(6): 963-973. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942014000600004&lng=es

16. Harrison. Principios de Medicina Interna [Internet]. 19a ed. McGraw-Hill Interamericana Editores, S.A; 2016. [citado 12/06/2019]. Disponible en: http://harrisonmedicina.mhmedical.com/content.aspx?bookid=1717&sectionid=114939901

17. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice [Internet]. 2019 [citado 10/08/2020]; 157: 107843. Disponible en: https://doi.org/10.1016/j.diabres.2019.107843

18. Montier Iglesias A, Cabezas Alfonso I, Díaz Cabrera JC, Linares Guerra EM, Jerez Hernández E. Efecto de la vitamina E sobre antioxidantes endógenos en ratas Wistar diabéticas. Rev Ciencias Médicas [Internet]. 2018 [citado 20/09/2020]; 22(3); 438-452. Disponible en: http://revcmpinar.sld.cu/index.php/publicaciones/article/view/3476/html

19. Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev. Assoc. Med. Bras [Internet]. 2019 [citado 20/10/2020]; 65(1): 9-15. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000100009&lng=en

20. Chen YY, Kao TW, Yang HF, Chou CW, Wu CJ, Lai CH, et al. The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects: an observational study. Clin Chim Acta [Internet]. 2018 [citado 20/10/2020]; 478: 68-73. Disponible en: https://doi.org/10.1016/j.cca.2017.12.038

Downloads

Published

2023-08-15

How to Cite

1.
Fuentes-de la Rosa Y, Díaz Cabrera JC, Díaz Calzada M, Rodríguez-Sardiñas LM, Pérez Alvarez Y. Characterisation of the metabolic syndrome in type 2 diabetics treated at the Provincial Centre of Pinar del Río. Rev Ciencias Médicas [Internet]. 2023 Aug. 15 [cited 2025 Sep. 18];27:e5861. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/5861

Issue

Vol. 27 (2023): (Sistema de Publicación Continua)

Section

ORIGINAL ARTICLES

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/